BAP1 GERMLINE MUTATION WITH IRIDOCILIOCHOROIDAL MELANOMA AND MALIGNANT PERITONEAL MESOTHELIOMA

Retin Cases Brief Rep. 2022 Mar 1;16(2):194-198. doi: 10.1097/ICB.0000000000000934.

Abstract

Purpose: BAP1 germline mutation can promote risk of uveal melanoma and mesothelioma. In this study, we report a patient with BAP1 germline mutation and uveal melanoma who developed a rare form of mesothelioma in the peritoneum.

Method: Case report.

Results: A 55-year-old white man noted blurred vision in the left eye. Examination revealed superotemporal episcleral sentinel vessels and a dark brown iris mass suspicious for melanoma, with angle invasion and involvement of the ciliochoroidal region. The tumor measured 14 mm in diameter and 10.3 mm in thickness. A diagnosis of iridociliochoroidal melanoma was rendered and plaque radiotherapy applied. Genetic testing revealed BAP1 germline mutation. At 3.5-year follow-up, tumor control was achieved, but radiation-related complications led to enucleation. At 5.5-year follow-up, incidental findings by laparoscopy revealed multiple peritoneal tumors, histopathologically proven to be malignant peritoneal mesothelioma. Lung evaluation was normal, and there was no melanoma-related or mesothelioma-related metastasis. Likewise, magnetic resonance imaging of the abdomen showed no evidence of hepatic metastasis.

Conclusion: BAP1 tumor predisposition syndrome can promote risk of uveal melanoma and malignant peritoneal mesothelioma. Cancer screening for these malignancies is warranted.

Publication types

  • Case Reports

MeSH terms

  • Genetic Predisposition to Disease
  • Germ-Line Mutation
  • Humans
  • Male
  • Melanoma* / genetics
  • Mesothelioma, Malignant* / genetics
  • Middle Aged
  • Peritoneal Neoplasms* / genetics
  • Tumor Suppressor Proteins* / genetics
  • Ubiquitin Thiolesterase* / genetics
  • Uveal Melanoma
  • Uveal Neoplasms* / genetics

Substances

  • BAP1 protein, human
  • Tumor Suppressor Proteins
  • Ubiquitin Thiolesterase